Skip to main content

At o2h Discovery, we seed new ideas in life sciences and work collaboratively to help transform scientific innovation into therapeutic opportunities. We have a proven track record of delivering high-quality integrated drug discovery services, partnering with biotechs to accelerate their research programmes.

We understand that generating the right ADME/DMPK data at the right stage is critical to progressing compounds efficiently and making confident go/no-go decisions. At o2h Discovery, we believe in making high-quality scientific services more accessible to biotech innovators.

In collaboration with One Nucleus, we have introduced an exclusive member benefit to help qualifying companies access early ADME expertise and generate meaningful preclinical data to advance their drug discovery programmes.

Offer to One Nucleus Members
Eligible One Nucleus members can access:
● $5,000 worth of ADME points/credits for a $1,000 participation fee 
or
● $10,000 worth of ADME points/credits for a $3,000 participation fee
If you are an active One Nucleus member and would like to access this exclusive programme, we'd be delighted to hear from you.

Register here

How do the points/credits work?
Participants receive prepaid testing points/credits that can be used towards eligible ADME studies. Credits are deducted only for the studies requested, allowing companies to access testing as and when needed throughout the programme period.

Who Can Apply?
This programme is open to active One Nucleus member organisations progressing drug discovery programmes, including biotech companies, pharmaceutical companies, university spinouts, and other life sciences organisations developing novel therapeutics.

How It Works

  • Complete the online application form with details about your company, therapeutic area, compound stage, and ADME requirements.
  • The o2h Discovery team will review your application and confirm eligibility within 3–4 business days.
  • Once approved, you'll be invited to pay the participation fee and schedule an introductory scientifi c discussion with our scientifi c team to understand your programme and align on the most appropriate studies.
  • Following execution of a Confi dential Disclosure Agreement (CDA), compounds can be shipped to our research facility in Ahmedabad, India.
  • Your ADME credits will be activated on the o2h Discovery platform (CITC), where you can request studies, monitor your available balance, and track usage.
  • Studies will be performed as required, with credits automatically deducted based on the selected assays. Results will be delivered together with scientifi c interpretation to support your programme.

    Programme Terms & Condition
  • One award per legal entity. Applicants must be an active paid member of One Nucleus.
  • The offer can only be redeemed once per company, irrespective of membership across multiple participating ecosystem enablers/organisations.
  • Points must be utilised within a defined period of 6 months.
  • Programme applicable to ADME services
  • $5,000 of ADME testing for $1,000 or $10,000 for a $3000 participation fee.
  • Work beyond the $5,000 credit invoiced at standard rates, agreed in advance.
  • Non-transferable and not redeemable for cash.
  • The project must be initiated within 6 months. No extensions.
  • Compounds shipped at applicant’s cost. CDA signed before any scientific discussion.
  • Final scope of work to be mutually agreed before study initiation.

  • o2h Discovery reserves the right to modify or withdraw the programme with notice.

    Please contact [email protected] for further details or any queries.


    About o2h Discovery
    At o2h co-discovery, we seed new ideas in life science. We have a proprietary operating system for fast tracking new ideas to a development candidate. The core is an integrated multi-modality drug discovery platform that combines novel capability with strategic partners embedded in AI enabled backbone to create a unique workfl ow. We are an insight driven team based out of Cambridge, UK/USA and Ahmedabad, India.

    For more information, visit: https://o2hdiscovery.co/